Radical surgery for mesothelioma;La chirurgie radicale dans le mésothéliome

Cancer/Radiotherapie

Volumn 11, Issue 1-2, 2007, Pages 101-104

  Bonnette, P ^a  

^a FOCH HOSPITAL   (France)

Author keywords

Mesothelioma; Pleuropneumonectomy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GEMCITABINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; HUMAN; LAPAROSCOPY; LUNG RESECTION; MESOTHELIOMA; PERICARDIOTOMY; PLEURECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SHORT SURVEY; THORACOSCOPY; THORAX RADIOGRAPHY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; PATHOLOGY; PLEURA; PLEURA TUMOR; REVIEW; TUMOR RECURRENCE;

CHEMOTHERAPY, ADJUVANT; HUMANS; LAPAROSCOPY; MESOTHELIOMA; NEOPLASM RECURRENCE, LOCAL; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; THORACOSCOPY;

EID: 34047117480     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.06.009     Document Type: Short Survey

References (18)

1. Ahamad A., Stevens C.W., Smythe W.R., Liao Z., Vaporciyan A.A., Rice D., et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J. 9 (2003) 476-484
2. Ahamad A., Stevens C.W., Smythe W.R., Vaporciyan A.A., Komaki R., Kelly J.F., et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 768-775
3. Baldini E.H., Recht A., Strauss G.M., DeCamp Jr. M.M., Swanson S.J., Liptay M.J., et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann. Thorac. Surg. 3 (1997) 334-338
4. Bonnette P., Bourg Heckly G., Vilette S., and Fragola A. Intraoperative photodynamic therapy after pleuropneumonectomy for malignant pleural mesotheliom. Chest 122 (2002) 1866-1867
5. Boutin C., Rey F., and Viallat J.R. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomised trial of local radiotherapy. Chest 108 (1995) 754-758
6. Ceresoli G.L., Zucali P.A., Favaretto A.G., Grossi F., Bidoli P., Del Conte G., et al. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J. Clin. Oncol. 24 (2006) 1443-1448
7. Erasmus J.J., Truong M.T., Smythe W.R., Munden R.F., Marom E.M., Rice D.C., et al. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J. Thorac. Cardiovasc. Surg. 129 (2005) 1364-1370
8. Favaretto A. Overview on ongoing or planned clinical trials in Europe. Lung Cancer 49 (2005) S117-S121
9. Flores R.M., Krug L.M., Rosenzweig K.E., Venkatraman E., Vincent A., Heelan R., et al. Induction chemotherapy, extrapleural pneumonectomy and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: aphase II trial. J. Thorac. Oncol. 1 (2006) 289-295
10. Hazarika M., White Jr. R.M., Booth B.P., Wang Y.C., Ham D.Y., Liang C.Y., et al. Pemetrexed in malignant pleural mesothelioma. Clin. Cancer Res. 11 (2005) 982-992
11. Maggi G., Casadio C., Cianci R., Rena O., and Ruffini E. Trimodality management of maligant pleural mesothelioma. Eur. J. Cardiothorac. Surg. 19 (2001) 346-350
12. Opitz I., Kestenholz P., Lardinois D., Muller M., Rousson V., Schneiter D., et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur. J. Cardiothorac. Surg. 29 (2006) 579-584
13. Rice D.C., Erasmus J.J., Stevens C.W., Vaporciyan Wu J.S., Tsao A.S., et al. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann. Thorac. Surg. 80 (2005) 1988-1993
14. Rusch V.W., Rosenzweig K., Venkatraman E., Leon L., Raben A., Harrison L., et al. A phase ll trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 122 (2001) 788-795
15. Stewart D.J., Martin-Ucar A.E., Edwards J.G., West K., and Waller D.A. Extrapleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur. J. Cardiothorac. Surg. 27 (2005) 373-378
16. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodalty therapy of malignant pleural mesothelioma: results in 183 patients. J. Thorac. Cardivasc. Surg. 17 (1999) 54-63
17. Sugarbaker D.J., Jaklitsch M.T., Bueno R., Richards W., Lukanich J., Mentzer S.J., et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J. Thorac. Cardiovasc. Surg. 128 (2004) 138-146
18. Weder W., Kestenholz P., Taverna C., Bodis S., Lardinois D., Jerman M., et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J. Clin. Oncol. 22 (2004) 2451-2457